Skip to content

An Open-Label Study of IDE034 in Adult Participants with Locally Advanced/Metastatic Solid Tumors

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-526299-21-00
Enrollment
15
Registered
2026-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

and castration-resistant prostate cancer (CRPC), colorectal cancer (CRC), endometrial cancer, esophageal squamous cell carcinoma (ESCC), head and neck squamous cell carcinoma (HNSCC), high-grade serous ovarian cancer (HGSOC), Locally Advanced/Metastatic Solid Tumors -non-small cell lung cancer (NSCLC), triple-negative breast cancer (TNBC)

Interventions

None listed

Sponsors

Ideaya Biosciences Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Outcome results

None listed

Source: EU CTIS · Data processed: Aug 29, 2026